TY - JOUR
T1 - Organoid models for cancer research
AU - Clevers, Hans
AU - Tuveson, David A.
N1 - Publisher Copyright:
© 2019 by Annual Reviews. All rights reserved.
PY - 2019
Y1 - 2019
N2 - Organoid cultures have emerged as powerful model systems accelerating discoveries in cellular and cancer biology. These three-dimensional cultures are amenable to diverse techniques, including high-throughput genome and transcriptome sequencing, as well as genetic and biochemical perturbation, making these models well suited to answer a variety of questions. Recently, organoids have been generated from diverse human cancers, including breast, colon, pancreas, prostate, bladder, and liver cancers, and studies involving these models are expanding our knowledge of the etiology and characteristics of these malignancies. Co-cultures of cancer organoids with non-neoplastic stromal cells enable investigation of the tumor microenvironment. In addition, recent studies have established that organoids have a place in personalized medicine approaches. Here, we describe the application of organoid technology to cancer discovery and treatment.
AB - Organoid cultures have emerged as powerful model systems accelerating discoveries in cellular and cancer biology. These three-dimensional cultures are amenable to diverse techniques, including high-throughput genome and transcriptome sequencing, as well as genetic and biochemical perturbation, making these models well suited to answer a variety of questions. Recently, organoids have been generated from diverse human cancers, including breast, colon, pancreas, prostate, bladder, and liver cancers, and studies involving these models are expanding our knowledge of the etiology and characteristics of these malignancies. Co-cultures of cancer organoids with non-neoplastic stromal cells enable investigation of the tumor microenvironment. In addition, recent studies have established that organoids have a place in personalized medicine approaches. Here, we describe the application of organoid technology to cancer discovery and treatment.
KW - cancer
KW - heterogeneity
KW - organoid
KW - personalized medicine
KW - tumoroid
KW - xenograft
UR - http://www.scopus.com/inward/record.url?scp=85071233278&partnerID=8YFLogxK
U2 - 10.1146/annurev-cancerbio-030518-055702
DO - 10.1146/annurev-cancerbio-030518-055702
M3 - Review article
AN - SCOPUS:85071233278
SN - 2472-3428
VL - 3
SP - 223
EP - 234
JO - Annual Review of Cancer Biology
JF - Annual Review of Cancer Biology
IS - 1
ER -